Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder
NCT07220460
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
Bipolar I or II Disorder
Interventions
DRUG:
ABBV-932
Sponsor
AbbVie